The U.S. Food and Drug Administration (FDA) has issued final guidance for developers of mobile health (mHealth) applications, with the agency saying it intends to exercise “enforcement discretion” for most apps because they pose minimal risk to consumers.
The U.S. Food and Drug Administration (FDA) has issued final guidance for developers of mobile health (mHealth) applications, with the agency saying it intends to exercise “enforcement discretion” for most apps because they pose minimal risk to consumers.
Leave a Reply
You must be logged in to post a comment.